Litcius/Paper detail

Safety of New Biologics (Vedolizumab and Ustekinumab) and Small Molecules (Tofacitinib) During Pregnancy: A Review

Javier P. Gisbert, María Chaparro

2020Drugs80 citationsDOI

Topics & Concepts

TofacitinibMedicineVedolizumabUstekinumabPregnancyPharmacotherapyDermatologyInternal medicineInfliximabDiseaseGeneticsBiologyRheumatoid arthritisInflammatory bowel diseasePregnancy and Medication ImpactReproductive System and PregnancyCOVID-19 Impact on Reproduction
Safety of New Biologics (Vedolizumab and Ustekinumab) and Small Molecules (Tofacitinib) During Pregnancy: A Review | Litcius